Literature DB >> 15514099

Liver dysfunction and steatosis in familial hypobetalipoproteinemia.

Amanda J Whitfield1, P Hugh R Barrett, Ken Robertson, Marek F Havlat, Frank M van Bockxmeer, John R Burnett.   

Abstract

A 32-year-old man presented with increases in serum alanine aminotransferase activity, iron concentration, and transferrin saturation, suggestive of hepatic dysfunction and iron overload. In addition, he had unusually low plasma concentrations of LDL-cholesterol and apolipoprotein (apo) B. Hepatic ultrasonography was consistent with fatty liver. On liver biopsy, marked steatosis and moderate to marked iron deposition were observed. The patient was found to carry the HFE C282Y and H63D mutations, which are associated with hereditary hemochromatosis, and the alpha(1)-antitrypsin PiZ variant. An immunoblot of plasma for apoB showed the presence of a truncated apoB species, indicative of familial hypobetalipoproteinemia. DNA sequence analysis revealed that the patient was heterozygous for the apoB-80.5 (c.11040T>G) mutation. This unique case shows an unusual combination of underlying disorders that could all be contributing to liver dysfunction and fatty liver.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514099     DOI: 10.1373/clinchem.2004.037978

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

Review 2.  Genetic determinants of hepatic steatosis in man.

Authors:  Amanda J Hooper; Leon A Adams; John R Burnett
Journal:  J Lipid Res       Date:  2011-01-18       Impact factor: 5.922

3.  Proteomic analysis of fructose-induced fatty liver in hamsters.

Authors:  Lihe Zhang; German Perdomo; Dae Hyun Kim; Shen Qu; Steven Ringquist; Massimo Trucco; H Henry Dong
Journal:  Metabolism       Date:  2008-08       Impact factor: 8.694

4.  Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia.

Authors:  Enza Di Leo; Lucia Magnolo; Sandra Lancellotti; Lory Crocè; Luca Visintin; Claudio Tiribelli; Stefano Bertolini; Sebastiano Calandra; Patrizia Tarugi
Journal:  J Med Genet       Date:  2006-12-08       Impact factor: 6.318

5.  Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD.

Authors:  Eduardo Vilar-Gomez; Samer Gawrieh; Tiebing Liang; Adam D McIntyre; Robert A Hegele; Naga Chalasani
Journal:  J Clin Lipidol       Date:  2020-12-27       Impact factor: 4.766

6.  Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.

Authors:  Mindy C W Lam; Janakie Singham; Robert A Hegele; Maziar Riazy; Matti A Hiob; Gordon Francis; Urs P Steinbrecher
Journal:  Case Rep Gastroenterol       Date:  2012-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.